Anti-Sm Antibody, Damage Index, and Corticosteroid Use Are Associated with Cardiac Involvement in Systemic Lupus Erythematosus: Data from a Prospective Registry Study.
Jung-Yoon ChoeShin-Seok LeeSang Gyu KwakSeong Kyu KimPublished in: Journal of Korean medical science (2020)
The results of this study reveal that SLE-related factors such as anti-Sm antibody, SDI, and corticosteroid dosage at baseline are risk factors for cardiac involvement in SLE.